NeuroPace Inc
NPCE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001528287
No open-market purchases or sales by NeuroPace Inc insiders were filed in the last 90 days; 112 institutions reported holding it in 13F filings for Q2 2026, worth $422.4M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in NeuroPace Inc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +4 vs. Q2 2023
- Shares held
- 18.1M
- +570.9K (+3.3%) vs. Q2 2023
- Total value
- $175.9M
- +$97.3M (+123.8%) vs. Q2 2023
- New holders
- 5
- 10 more added
- Sold out
- 1
- 5 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NPCE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 112 | $422.4M |
| Q1 2026 | 113 | $347.9M |
| Q4 2025 | 100 | $405.9M |
| Q3 2025 | 80 | $267.5M |
| Q2 2025 | 99 | $250.7M |
| Q1 2025 | 90 | $294.1M |
| Q4 2024 | 62 | $233.5M |
| Q3 2024 | 48 | $103.1M |
| Q2 2024 | 51 | $109.1M |
| Q1 2024 | 54 | $176.4M |
| Q4 2023 | 41 | $130.8M |
| Q3 2023 | 25 | $175.9M |
| Q2 2023 | 22 | $78.6M |
| Q1 2023 | 24 | $82.0M |
| Q4 2022 | 24 | $25.9M |
| Q3 2022 | 28 | $68.1M |
| Q2 2022 | 32 | $91.2M |
| Q1 2022 | 40 | $149.5M |
| Q4 2021 | 41 | $181.5M |
| Q3 2021 | 39 | $177.4M |
| Q2 2021 | 44 | $259.5M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding NeuroPace Inc; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 4 | $0 | 0.00% | −337−98.8% | Reduced |
| UBS Group AG | 55 | $535 | 0.00% | +55 | New |
| Wells Fargo & Company | 74 | $720 | 0.00% | −149−66.8% | Reduced |
| Federated Hermes, Inc. | 424 | $4.13K | 0.00% | +424 | New |
| Qube Research & Technologies Ltd | 2,399 | $23.3K | 0.00% | +2,399 | New |
| Citigroup Inc | 2,984 | $29.0K | 0.00% | +2,984 | New |
| Bank of America Corp | 5,500 | $53.5K | 0.00% | 00.0% | Unchanged |
| Financial Advocates Investment Management | 10,000 | $97.3K | 0.01% | 00.0% | Unchanged |
| Barclays PLC | 10,839 | $105.5K | 0.00% | +10,721+9,085.6% | Added |
| Northern Trust Corp | 22,201 | $216.0K | 0.00% | +6,095+37.8% | Added |
| State Street Corp | 33,251 | $323.5K | 0.00% | +10,800+48.1% | Added |
| Renaissance Technologies LLC | 44,285 | $431.0K | 0.00% | +26,985+156.0% | Added |
| BlackRock Inc. | 59,968 | $583.5K | 0.00% | +23,851+66.0% | Added |
| Bridgeway Capital Management, LLC | 60,048 | $584.3K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 110,209 | $1.07M | 0.00% | +38,694+54.1% | Added |
| EAM Investors, LLC | 141,616 | $1.38M | 0.27% | +141,616 | New |
| Millennium Management LLC | 184,169 | $1.79M | 0.00% | −444,764−70.7% | Reduced |
| Vanguard Group Inc | 386,085 | $3.76M | 0.00% | +7,898+2.1% | Added |
| Kent Lake Capital LLC | 574,417 | $5.59M | 2.18% | +425,212+285.0% | Added |
| FMR LLC | 706,245 | $6.87M | 0.00% | −517,418−42.3% | Reduced |
| Nantahala Capital Management, LLC | 1,219,915 | $11.9M | 1.51% | +795,065+187.1% | Added |
| Morgan Stanley | 2,399,716 | $23.3M | 0.00% | +40,850+1.7% | Added |
| Soleus Capital Management, L.P. | 2,466,205 | $24.0M | 2.42% | −90.0% | Reduced |
| OrbiMed Advisors LLC | 4,012,281 | $39.0M | 0.90% | 00.0% | Unchanged |
| KCK Ltd. | 5,621,111 | $54.7M | 77.70% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| BerganKDV Wealth Management, LLC | – | – | – | – | Not filed |